PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. Food and Drug Administration (FDA). Breyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD) and will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
Global pharma major Lupin Limited (Lupin) today announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, to market a generic equivalent of Perforomist® Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P. Formoterol Fumarate Inhalation Solution (RLD Perforomist®) had estimated annual sales of USD 268 million in the U.S. (IQVIA MAT September 2022).
Aucta's Generic Formoterol Fumarate Receives Approval in the U.S.
Lupin gets USFDA nod for Formoterol Fumarate inhalation solution
Lupin's Generic Formoterol Fumarate Receives Approval in the U.S.
Chiesi Limited has announced that the Scottish Medicines Consortium (SMC) has recommended Trimbow – comprised of beclometasone dipropionate, formoterol, glycopyrronium – as an option for use within NHS Scotland.
Mylan's Generic Budenoside and Formoterol Fumarate Receives Approval in the U.S.
Astrazeneca's Biologic Riltrava Aerosphere Receives Approval in Europe
Alembic Pharma's Generic Formoterol Fumarate Receives Approval in the US